Riboflavin supplementation and biomarkers of cardiovascular disease in the elderly.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/19390751
Conclusion of this study
In this elderly group, we found that 10 mg/day oral riboflavin supplementation lowered plasma homocysteine concentrations in subjects with low riboflavin status.
Supplements analyzed in this study
|
Health conditions analyzed in this study
No health conditions information for this study.Functions related to this study
|
||
|
Body systems related to this study
 Cardiovascular System |
